Improving Access, Affordability and Adherence
We apply our expertise to initiatives and services designed to help patients with access, affordability and adherence.
Our Partners
Navigating Healthcare Together
Bringing our purpose of Advancing Health Outcomes for All® to life is a collaborative effort. At McKesson, we actively build and nurture partnerships with biopharma companies, care providers, pharmacies, manufacturers, governments and others, working together to make a meaningful difference for those who rely on us through our insights, products and services.
Advancing Oncology Care
As we strive to make a world without cancer a reality, we continue to help oncologists provide their patients with the treatment, care and support they need.
Partnering with Our Government
Offering our unique perspective and expertise, we collaborate with policymakers, elected officials and other stakeholders for the benefit of patients everywhere.
Bringing Hope to One Patient at a Time: Mike’s Story
When Mike learned he would need advanced treatment for his cancer, he faced uncertainty about where to turn for care and support.
At Sarah Cannon Research Institute (SCRI), McKesson's oncology research joint venture, Mike found not only access to cutting-edge clinical trials but also a team committed to walking alongside him every step of the way. His journey reflects the power of research, innovation and compassionate care working together to make a difference for patients.
Watch Mike’s story and see how SCRI is helping bring hope to patients when it matters most.
How We're Improving Access, Affordability and Adherence
We apply our expertise to initiatives and services designed to help patients with access, affordability and adherence. We also seek partnerships to understand and address the many factors that create barriers and hinder patient access to the medications they need. We do this by:
Distributing supplies, services and solutions
Increasing patient access through community pharmacies
Creating prescription access, affordability and adherence solutions
Investing in startups to advance patient outcomes
How We're Advancing in Oncology & Multispecialty
Over the last 20 years, McKesson has advanced cancer and specialty care by empowering community providers and supporting them through the many challenges they face today, from administrative burdens and financial pressures to the complexity of connecting patients to the next generation of therapies. We also partner with biopharma to accelerate the delivery of next-generation therapies and support the drug lifecycle through separate, non-clinical capabilities to ensure therapies are delivered safely and reliably.
Expanding clinical trial access and improving patient outcomes
Clinical trials are critical to advancing cancer care, but these studies rely on volunteers and participation barriers often limit access and slow progress. Through the collaboration between Sarah Cannon Research Institute (SCRI) and The US Oncology Network, McKesson is expanding clinical trial access across community oncology settings — bringing research closer to patients. SCRI’s research network includes more than 1,500 physicians at over 200 locations in 20 states across the U.S., supporting much of the innovation behind today’s cancer therapies. To support this scale, SCRI leverages Accelero™, a framework that helps launch trials faster, reduce operational complexity and ease administrative burden for providers. With over 900 first-in-human clinical trials to date, SCRI is improving patient access to promising treatments closer to home — accelerating discovery while integrating research into everyday care.
Spotlight
McKesson Amplify Powers Pharmacist Advocacy
In June 2024, we introduced McKesson Amplify to fund state pharmacy associations across the country to fuel advocacy, expand outreach and strengthen the profession from the ground-up. In its first full year, McKesson Amplify provided funding to every eligible state pharmacy association which applied and met program qualifications. The support translated into meaningful impact, as funding supported new initiatives and the ability to host advocacy events at a scale that wouldn’t have been possible otherwise.
How We’re Supporting Our Government
We recognize that collaboration across the public and private sector is key to strengthening care today and into the future. That’s why we continue to advocate for policies that remove barriers to care, strengthen healthcare infrastructure and accelerate innovation — ensuring patients can access care when they need it.
McKesson sees these partnerships as valuable opportunities to educate and inform. Drawing on our expertise across healthcare, we share insights that help elected and appointed officials understand the solutions we offer and the challenges facing today’s providers, patients and supply chains. Our goal is to provide practical perspectives that support thoughtful policy making, improving outcomes for local communities, industry, businesses, customers and the patients they serve.
Our Approach to Supplier Engagement
At McKesson, we are committed to sourcing quality products and services for our customers and employees. Our Supplier Engagement Program aligns with our purpose of Advancing Health Outcomes for All® by seeking collaborative, win-win solutions with our supplier partners.